Ads
related to: breakthrough dementia treatment- Getting Started
Read Infusion FAQs & Tips For
Getting Started With Treatment.
- Alzheimer's Disease Info
Learn About the Stages of AD &
Diagnostic Tests for Patients.
- For Care Partners
Help Support Your Loved One. See
Helpful Tips & Resources.
- Support & Resources
Access Downloadable Patient
Resources Available On-Site.
- Getting Started
Search results
Results From The WOW.Com Content Network
A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease.
The study, published in the Journal of the American Medical Association, concluded that after 76 weeks of treatment, Donanemab was able to slow clinical decline by 35.1% in people with early ...
Patients could be getting breakthrough Alzheimer’s drug in a year, experts have said, but only a small proportion of patients will benefit unless more is done to boost dementia services in the NHS.
Solanezumab was safely used in combination with approved Alzheimer's disease treatment, such as acetylcholinesterase inhibitors or memantine, in the clinical trials. [1] [7] [8] Aside from Alzheimer's disease, there are other amyloid beta related diseases, in which solanezumab could be used, e.g., Down syndrome or cerebral amyloid angiopathy. [9]
[9] [10] The final conclusion was that "verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer’s disease and was associated with treatment-related adverse events". Verubecestat was projected to be a breakthrough medicine for dementia related illness, however it is still unknown why the medicine ...
A study of autopsies of people diagnosed with Alzheimer's disease found that only 3% had Alzheimer's alone; 15% had a form of dementia that was not Alzheimer's, and 82% had more than one kind of ...
Ads
related to: breakthrough dementia treatment